Activation of oncogenic pathways in idiopathic pulmonary fibrosis

Giulia M. Stella, Simona Inghilleri, Ymera Pignochino, Michele Zorzetto, Tiberio Oggionni, Patrizia Morbini, Maurizio Luisetti

Research output: Contribution to journalArticlepeer-review


Idiopathic pulmonary fibrosis (IPF) is defined as a specific formof chronic, progressive fibrosing interstitial pneumonia of unknown cause. The most recent hypotheses on IPF pathogenesis suggest a central role of epithelial cell damage, followed by a dysregulated molecular cross talk between epithelial cells and fibroblasts. Thus, IPF progression has often been assimilated to that of cancer, and several signaling patterns appear to be disrupted in both diseases. Here,we analyze the expression in an IPF series of a panel of molecules, which are known to play a role in tumorigenic process. Our findings, although preliminary, reveal that IPF landscape is enriched in neoplastic potential expressed in a context of complex genomic polyclonality and cellular heterogeneity. These results provide a rationale for further investigations aimed to exploit—in a similar fashion to cancer—targeted therapies for a “precisionmedicine” approach to IPF.

Original languageEnglish
Pages (from-to)650-655
Number of pages6
JournalTranslational Oncology
Issue number5
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Activation of oncogenic pathways in idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.

Cite this